title: Chronic hyperosmolality increases NHE3 activity in OKP cells.
abstract: This study investigated the effect of chronic hypertonicity on the OKP cell Na/H antiporter, encoded by Na/H exchanger 3 (NHE3). Chronic (48 h) increases in extracellular glucose, mannitol, or raffinose concentration caused a significant increase in Na/H antiporter activity, while increases in urea concentration were without effect. This effect was seen with changes in osmolality of only 20 mOsm/liter, a magnitude that is observed clinically in poorly controlled diabetes mellitus. Increases in mannitol concentration acutely inhibited and chronically stimulated Na/H antiporter activity. The increase in Na/H antiporter activity induced by hypertonic incubation was resistant to 10(-7) and 5 x 10(-6) M but inhibited by 10(-4) M ethylisopropyl amiloride, consistent with regulation of NHE3. In addition, hypertonicity increased total cellular and plasma membrane NHE3 protein abundance twofold, with only a small increase in NHE3 mRNA abundance. We conclude that chronic pathophysiologically relevant increases in tonicity lead to increases in NHE3 protein abundance and activity. This may be responsible for increased proximal tubule apical membrane Na/H antiporter activity in poorly controlled diabetes mellitus, which could then contribute to hypertension, glomerular hyperfiltration and diabetic nephropathy.
authors.affiliation: Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75235-8856, USA.
authors.forename: P
authors.initials: P
authors.lastname: Ambühl
authors.forename: M
authors.initials: M
authors.lastname: Amemiya
authors.forename: P A
authors.initials: PA
authors.lastname: Preisig
authors.forename: O W
authors.initials: OW
authors.lastname: Moe
authors.forename: R J
authors.initials: RJ
authors.lastname: Alpern
mesh_terms: D000584:Amiloride / Q000031:analogs & derivatives; D000818:Animals; D002460:Cell Line; D003470:Culture Media / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006982:Hypertonic Solutions; D007668:Kidney / Q000166:cytology / Q000378:metabolism*; D008353:Mannitol / Q000494:pharmacology; D009893:Opossums; D009994:Osmolar Concentration; D011887:Raffinose / Q000494:pharmacology; D000074083:Sodium-Hydrogen Exchanger 3; D017923:Sodium-Hydrogen Exchangers / Q000235:genetics / Q000378:metabolism*; D014508:Urea / Q000494:pharmacology
chemical_list: D003470:Culture Media; D006982:Hypertonic Solutions; D000074083:Sodium-Hydrogen Exchanger 3; D017923:Sodium-Hydrogen Exchangers; D008353:Mannitol; D000584:Amiloride; D014508:Urea; D005947:Glucose; D011887:Raffinose; C039614:ethylisopropylamiloride